- Home
- TLF vs RVPH Comparison
TLF vs RVPH Comparison
Compare TLF & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLF
- RVPH
- Stock Information
- Founded
- TLF 1980
- RVPH 2006
- Country
- TLF United States
- RVPH United States
- Employees
- TLF N/A
- RVPH N/A
- Industry
- TLF Apparel
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- TLF Consumer Discretionary
- RVPH Health Care
- Exchange
- TLF Nasdaq
- RVPH Nasdaq
- Market Cap
- TLF N/A
- RVPH 32.8M
- IPO Year
- TLF N/A
- RVPH N/A
- Fundamental
- Price
- TLF $3.15
- RVPH $0.36
- Analyst Decision
- TLF
- RVPH Strong Buy
- Analyst Count
- TLF 0
- RVPH 5
- Target Price
- TLF N/A
- RVPH $9.00
- AVG Volume (30 Days)
- TLF 10.2K
- RVPH 2.6M
- Earning Date
- TLF 08-06-2025
- RVPH 08-13-2025
- Dividend Yield
- TLF 47.62%
- RVPH N/A
- EPS Growth
- TLF 241.69
- RVPH N/A
- EPS
- TLF 1.47
- RVPH N/A
- Revenue
- TLF $74,152,000.00
- RVPH N/A
- Revenue This Year
- TLF N/A
- RVPH N/A
- Revenue Next Year
- TLF N/A
- RVPH N/A
- P/E Ratio
- TLF $2.18
- RVPH N/A
- Revenue Growth
- TLF N/A
- RVPH N/A
- 52 Week Low
- TLF $2.69
- RVPH $0.30
- 52 Week High
- TLF $5.48
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- TLF 56.39
- RVPH 31.07
- Support Level
- TLF $3.02
- RVPH $0.35
- Resistance Level
- TLF $3.19
- RVPH $0.40
- Average True Range (ATR)
- TLF 0.09
- RVPH 0.07
- MACD
- TLF 0.01
- RVPH -0.03
- Stochastic Oscillator
- TLF 80.00
- RVPH 15.15
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.